

Boehringer Ingelheim's successes in research & development continuously strengthen our portfolio of medications and offer patients true therapeutic benefit. The company focuses on six major research areas: CardioMetabolic diseases, Central nervous system diseases, Immunology and Inflammation, Infectious diseases, Oncology and Respiratory diseases.
Within our areas of therapeutic focus we are looking to build our expertise and partner with academic institutions, non-profit research centres and biotechnology companies to embrace all stages of the research continuum:
Current translation of medical science into effective treatments is poor. We want to improve our understanding of the underlying mechanisms and causes of disease so we can contribute to biological knowledge and search for treatments that will treat disease more effectively.
Current translation of medical science into effective treatments is poor. We want to improve our understanding of the underlying mechanisms and causes of disease so we can contribute to biological knowledge and search for treatments that will treat disease more effectively. Click here to see an example of Discovering together.
With ever changing scientific horizons we know we need to work with external knowledge centres to gain access to new and evolving technologies so we can strive for excellence in both small molecule and biological treatments. Click here to see an example of Discovering together.
We also seek partnerships, in our areas of therapeutic focus, where we can work together to discover and develop new projects. Click here to see an example of Discovering together.
View details on our partnering website.